BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 5540057)

  • 1. Effect of ergocornine on prolactin secretion by hypophysial homografts.
    Malven PV; Hoge WR
    Endocrinology; 1971 Feb; 88(2):445-9. PubMed ID: 5540057
    [No Abstract]   [Full Text] [Related]  

  • 2. Direct inhibition by ergocornine of pituitary prolactin release.
    Lu KH; Koch Y; Meites J
    Endocrinology; 1971 Jul; 89(1):229-33. PubMed ID: 5089657
    [No Abstract]   [Full Text] [Related]  

  • 3. Structural luteolysis following transplantation of hypophysial homografts in hypophysectomized rats.
    Sloan CS; Malven PV
    Endocrinology; 1969 Mar; 84(3):606-10. PubMed ID: 5812987
    [No Abstract]   [Full Text] [Related]  

  • 4. Effect of ergocornine on transplanted mammary tumor growth and pituitary prolactin level in BALB/c mice.
    Singh DV; Meites J; Halmi L; Kortright KH; Brennan MJ
    J Natl Cancer Inst; 1972 Jun; 48(6):1727-31. PubMed ID: 5056256
    [No Abstract]   [Full Text] [Related]  

  • 5. [Inhibition of prolactin secretion by ergocornine and 2-Br-alpha-ergocryptine: direct action on the hypophysis in culture].
    Pasteels JL; Danguy A; Frérotte M; Ectors F
    Ann Endocrinol (Paris); 1971; 32(1):188-92. PubMed ID: 5556257
    [No Abstract]   [Full Text] [Related]  

  • 6. Suppression of mammary hyperplastic nodule formation and pituitary prolactin secretion in mice induced by ergocornine or 2-bromo-a-ergocryptine.
    Yanai R; Nagasawa H
    J Natl Cancer Inst; 1970 Dec; 45(6):1105-12. PubMed ID: 5530649
    [No Abstract]   [Full Text] [Related]  

  • 7. Inhibition of lactation and prolactin secretion in rats by ergot alkaloids.
    Shaar CJ; Clemens JA
    Endocrinology; 1972 Jan; 90(1):285-8. PubMed ID: 5009064
    [No Abstract]   [Full Text] [Related]  

  • 8. Inhibition of mammary tumorigenesis by ergot alkaloids and promotion of mammary tumorigenesis by pituitary isografts in adreno-ovariectomized mice.
    Yanai R; Nagasawa H
    J Natl Cancer Inst; 1972 Mar; 48(3):715-9. PubMed ID: 5058970
    [No Abstract]   [Full Text] [Related]  

  • 9. Effect of ergocornine on perphenazine-and oestrogen-induced prolactin release.
    Kulkarni PN; Simpson AA
    J Endocrinol; 1974 Oct; 63(1):35-41. PubMed ID: 4418486
    [No Abstract]   [Full Text] [Related]  

  • 10. Effects of ergocornine and ergocryptine on growth of 7,12-dimethylbenzanthracene-induced mammary tumors in rats.
    Cassell EE; Meites J; Welsch CW
    Cancer Res; 1971 Jul; 31(7):1051-3. PubMed ID: 5560385
    [No Abstract]   [Full Text] [Related]  

  • 11. Stimulation of estrogen secretion from normal rat corpora lutea by luteinizing hormone.
    Macdonald GJ; Armstrong DT; Greep RO
    Endocrinology; 1966 Aug; 79(2):289-93. PubMed ID: 5950836
    [No Abstract]   [Full Text] [Related]  

  • 12. Median eminence lesions and serum prolactin: influence of ovariectomy and ergocornine.
    Welsch CW; Squiers MD; Cassell E; Chen CL; Meites J
    Am J Physiol; 1971 Dec; 221(6):1714-7. PubMed ID: 4941908
    [No Abstract]   [Full Text] [Related]  

  • 13. Effect of median eminence lesions on the function of multiple pituitary homografts with particular reference to the secretion of gonadotrophins and growth hormone.
    Beddow DG; McCann SM
    Endocrinology; 1969 Mar; 84(3):595-605. PubMed ID: 4886349
    [No Abstract]   [Full Text] [Related]  

  • 14. Hormonal dependence of cholesterol ester hydrolase in the corpus luteum and adrenal.
    Behrman HR; Greep RO
    Horm Metab Res; 1972 May; 4(3):206-9. PubMed ID: 4339762
    [No Abstract]   [Full Text] [Related]  

  • 15. Effects of ergocornine on the mechanism of gestation and on fetal morphology in the rat.
    Carpent G; Desclin L
    Endocrinology; 1969 Feb; 84(2):315-24. PubMed ID: 5764305
    [No Abstract]   [Full Text] [Related]  

  • 16. Comparative effects of hypophysectomy, ergocornine and ergocornine-reserpine treatments on rat mammary carcinoma.
    Welsch CW; Iturri G; Meites J
    Int J Cancer; 1973 Jul; 12(1):206-12. PubMed ID: 4790704
    [No Abstract]   [Full Text] [Related]  

  • 17. Effect of 2-Br-alpha-ergocryptine on pituitary synthesis and release of prolactin and growth hormone in rats.
    Yanai R; Nagasawa H
    Horm Res; 1974 Jan; 5(1):1-5. PubMed ID: 4810405
    [No Abstract]   [Full Text] [Related]  

  • 18. Follicular stimulation by chronic treatment with synthetic LH-releasing hormone in hypophysectomized female rats bearing pituitary grafts.
    Arimura A; Debeljuk L; Shiino M; Rennels EG; Schally AV
    Endocrinology; 1973 May; 92(5):1507-14. PubMed ID: 4571984
    [No Abstract]   [Full Text] [Related]  

  • 19. Studies on the mechanism of nidation. 13. Effect of ergocornine in pregnant rats during experimentally induced delayed nidation.
    Varavudhi P; Lobel BL; Shelesnyak MC
    J Endocrinol; 1966 Apr; 34(4):425-30. PubMed ID: 5933096
    [No Abstract]   [Full Text] [Related]  

  • 20. Inhibition by ergocornine and 2-Br-alpha-ergocryptin of spontaneous mammary tumor appearance in mice.
    Yanai R; Nagasawa H
    Experientia; 1971 Aug; 27(8):934-5. PubMed ID: 5147266
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.